Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia
This study has been completed.
First Posted: July 6, 2011
Last Update Posted: July 6, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Information provided by:
Oslo University Hospital
The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.
||Observational Model: Case Control
Time Perspective: Retrospective
Biospecimen Retention: Samples Without DNA
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||May 2004 (Final data collection date for primary outcome measure)
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:
||20 Years to 43 Years (Adult)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Case-control study consisting of 43 women developping preeclampsia and 86 women not developping this disorder. All were of Caucasian origin and were nulliparous.
- preexisting cardiovascular diseases,
- inflammatory bowel diseases,
- serious organ diseases, and
- development of separate gestational diabetes and/or hypertension.
No Contacts or Locations Provided
||Oslo University Hospital, Department of Medical Biochemistry
History of Changes
|Other Study ID Numbers:
||June 30, 2011
||July 6, 2011
|Last Update Posted:
||July 6, 2011
Keywords provided by Oslo University Hospital:
Additional relevant MeSH terms: